Florida online MAT regulations 2026: what patients need to know

2026 Florida compliance: quick reference

Key Takeaways

• Online Suboxone treatment for OUD is legal in Florida in 2026. Florida's Schedule II telehealth restriction does not apply to buprenorphine, which is Schedule III under both federal and Florida law.
• Florida's SB 312 (2022), codified in § 456.47, narrowed an earlier blanket restriction. It now prohibits telehealth prescribing only for Schedule II controlled substances, with specific exceptions. Schedule III-V controlled substances, including buprenorphine, can be prescribed via telehealth under Florida law.
• Federal rules further support telehealth access. The DEA/HHS Fourth Temporary Extension (through December 31, 2026) and the permanent Expansion of Buprenorphine Treatment via Telemedicine Encounter rule (effective December 31, 2025) both permit new patient initiation via telehealth without a prior in-person evaluation.
• Florida practitioners must check E-FORCSE, Florida's PDMP, before prescribing. This applies to all controlled substance prescriptions, including buprenorphine, regardless of whether the visit is in-person or telehealth.
• Audio-video is the standard for Florida telehealth. Florida's telehealth law requires audio-video technology for standard telehealth encounters. While the federal buprenorphine permanent rule permits audio-only at the federal level, Florida providers operating under Florida licensure must meet Florida's technology standards. Patients should expect video visits rather than phone-only calls for evaluations in Florida.

Understanding Florida's telehealth controlled substances law

The Schedule II restriction (SB 312 / § 456.47)

Before 2022, Florida's telehealth law prohibited prescribing any controlled substance via telehealth, with limited exceptions. In 2022, the Florida Legislature passed SB 312, which amended § 456.47, Florida Statutes, to narrow the prohibition. Under current law:

• Schedule II controlled substances may not be prescribed via telehealth in Florida, with four exceptions: treatment of a psychiatric disorder, inpatient hospital treatment, hospice patients, and nursing home residents.
• Schedule III-V controlled substances can be prescribed via telehealth in Florida, within the scope of the practitioner's license and in accordance with other state and federal law.

Buprenorphine is classified as a Schedule III controlled substance by the DEA. Florida follows the federal scheduling. This means buprenorphine/naloxone (Suboxone) falls in the Schedule III category and is not subject to the Schedule II telehealth restriction in Florida.

Note for legal clarity: The psychiatric disorder exception in § 456.47 for Schedule II substances is also relevant here. OUD is classified as a mental health condition (Substance Use Disorder) in the DSM-5. This means that even for Schedule II substances, treatment of OUD may qualify under the psychiatric disorder exception. However, since buprenorphine is Schedule III and does not require invoking this exception, practitioners prescribing buprenorphine for OUD are not dependent on it. Verify current § 456.47 language and any 2025-2026 legislative amendments before relying on this exception.

How Florida and federal rules interact

Both Florida law and federal law must be satisfied when prescribing buprenorphine via telehealth to Florida patients.

Florida law permits Schedule III-V telehealth prescribing under § 456.47 and requires:

• The prescriber to hold a valid Florida license
• Compliance with Florida Board of Medicine or applicable board standards of care
• Standard medical evaluation sufficient to diagnose and treat
• E-FORCSE PDMP check before prescribing
• Electronic prescription transmission

Federal law (under the Fourth Temporary Extension and permanent buprenorphine rule) permits:

• Prescribing buprenorphine without prior in-person evaluation
• New patient initiation via telehealth
• Initial buprenorphine supply via telehealth (up to 6 months under the permanent rule; broader flexibility under the temporary extension through 2026)

Both must be satisfied simultaneously. A practitioner prescribing to a Florida patient via telehealth must comply with both Florida's telehealth and prescribing standards and the DEA's telehealth requirements.

E-FORCSE: Florida's prescription drug monitoring program

E-FORCSE (Electronic-Florida Online Reporting of Controlled Substances Evaluated) is Florida's prescription drug monitoring program. Florida law requires prescribers to check E-FORCSE before prescribing a controlled substance.

For buprenorphine prescriptions in Florida:

• The prescriber checks E-FORCSE before the first prescription and at subsequent refills
• The check identifies potential drug interactions, conflicting prescriptions, and patterns that may indicate misuse
• Documentation of the E-FORCSE check date and time is required in the medical record
• This requirement applies equally to telehealth prescriptions and in-person prescriptions

Bicycle Health providers access E-FORCSE as part of the standard clinical workflow for Florida patients. This check is part of the evaluation process during your video visit.

Electronic prescribing in Florida

Florida requires that controlled substance prescriptions be transmitted electronically. Buprenorphine prescriptions in Florida must be e-prescribed to the pharmacy. Paper prescriptions for controlled substances are not permitted in standard circumstances.

Bicycle Health uses secure, DEA-compliant electronic prescribing. Prescriptions are sent directly to your chosen pharmacy's system from the provider's clinical platform. No paper prescription is needed, and there is nothing for you to hand to the pharmacy.

Audio-video requirements for Florida telehealth

Florida's telehealth law requires audio-video technology for standard telehealth evaluations. The federal permanent buprenorphine telemedicine rule (90 FR 6504) permits audio-only encounters for buprenorphine OUD treatment at the federal level. However, Florida practitioners must simultaneously comply with Florida law, which requires audio-video for telehealth.

Practical result: Florida patients will generally need audio-video capability (smartphone, tablet, or computer with camera) for their Bicycle Health visits. Phone-only calls are not the standard pathway for Florida telehealth evaluations under Florida law.

If you do not have video capability, contact Bicycle Health prior to your appointment to discuss what options may be available in your specific situation.

Florida pharmacy access

Florida pharmacists are required to verify the legitimacy of prescriptions before dispensing controlled substances. They may not refuse to fill a valid prescription from a Florida-licensed provider solely because it was issued via telehealth. A telehealth buprenorphine prescription from a licensed Florida prescriber is legally equivalent to an in-person prescription.

Practical notes for Florida patients:

• Major pharmacy chains in Florida (Publix, CVS, Walgreens, Winn-Dixie pharmacy) generally maintain buprenorphine/naloxone stock, though calling ahead to confirm your specific dose is advisable
• Generic buprenorphine/naloxone is substantially less expensive than brand-name Suboxone and is available at most Florida pharmacies
• Mail-order pharmacy is an option that eliminates the in-person pickup requirement

Bicycle Health's compliance in Florida

Bicycle Health operates in Florida and provides telehealth MAT to Florida patients. Florida providers on the Bicycle Health network:

• Hold valid Florida medical licenses
• Maintain DEA registrations with Schedule III prescribing authority
• Use HIPAA-compliant video platforms for all visits
• Conduct E-FORCSE checks as part of every prescribing encounter
• Use electronic prescribing for all controlled substance prescriptions
• Follow Florida Board of Medicine standards of care for telehealth encounters

Frequently Asked Questions

Is it legal to get Suboxone online in Florida in 2026?

Yes. Florida's telehealth law restricts telehealth prescribing of Schedule II controlled substances. Buprenorphine (Suboxone) is Schedule III under both federal and Florida law, placing it outside the Schedule II restriction. Combined with the DEA Fourth Temporary Extension (through December 31, 2026) and the permanent federal buprenorphine telemedicine rule (effective December 31, 2025), Florida patients can be evaluated and prescribed buprenorphine via telehealth without a prior in-person visit.

Why does Florida restrict Schedule II telehealth but not Schedule III?

Florida's SB 312 (2022) was specifically designed to permit telehealth prescribing of Schedule III-V controlled substances while maintaining stricter rules for Schedule II drugs, which include higher-potency opioids, stimulants, and other substances with higher abuse potential. Buprenorphine (Schedule III) and benzodiazepines like alprazolam (Schedule IV) are in the less-restricted category under Florida's law.

Do I need to use video for my Florida Suboxone visits?

Florida's telehealth law requires audio-video technology for standard telehealth evaluations. You will generally need a smartphone, tablet, or computer with a camera for your Bicycle Health visits. The federal buprenorphine permanent rule permits audio-only at the federal level, but Florida state law requirements apply to Florida-licensed providers serving Florida patients. Contact Bicycle Health if you do not have video access.

What is E-FORCSE and why does my provider check it?

E-FORCSE is Florida's prescription drug monitoring program. Florida law requires prescribers to check E-FORCSE before prescribing controlled substances. Your provider reviews your prescription history to identify potential drug interactions, conflicting prescriptions, or other safety concerns before prescribing buprenorphine. This is a safety measure that is part of every prescribing encounter for Florida patients.

What happens to Florida patients after December 31, 2026?

The DEA Fourth Temporary Extension covers telehealth buprenorphine prescribing through December 31, 2026. After that date, the permanent buprenorphine rule provides a pathway but limits telehealth prescribing to an initial six-month supply before requiring an in-person visit under its specific framework. The DEA may issue further extensions or permanent regulations before year-end. Florida's state law (§ 456.47) permitting Schedule III telehealth prescribing is permanent and not affected by federal rule changes. This page will be updated as guidance changes.